Technical Analysis for VSTM - Verastem, Inc.

Grade Last Price % Change Price Change
C 2.67 -0.74% -0.02
VSTM closed up 0.37 percent on Thursday, April 15, 2021, on 33 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical VSTM trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion -0.74%
Spinning Top Other -0.37%
NR7 Range Contraction -0.37%
Wide Bands Range Expansion -0.37%
180 Bullish Setup Bullish Swing Setup -1.11%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.11%
Wide Bands Range Expansion -1.11%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.89%
Wide Bands Range Expansion 3.89%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.26%
Older End-of-Day Signals for VSTM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
Fell Below Previous Day's Low about 3 hours ago
Up 1% about 3 hours ago
Down 1% about 24 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib testing in ovarian cancer, as well as developing for the treatment of mesothelioma and breast cancer. It is also developing FAK inhibitor VS-4718 and PI3K/mTOR inhibitor VS-5584 in patients with advanced cancers. The company's product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Breast Cancer Stem Cells Treatment Of Breast Cancer Ovarian Cancer Companion Diagnostic Signal Transduction Helio Cancer Research Metastasis mTOR Mesothelioma Advanced Cancer Advanced Cancers Aggressive Cancers Cancer Stem Cell Cancer Stem Cells Phosphoinositide 3 Kinase

Is VSTM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.66
52 Week Low 1.08
Average Volume 2,621,600
200-Day Moving Average 1.83
50-Day Moving Average 2.46
20-Day Moving Average 2.55
10-Day Moving Average 2.72
Average True Range 0.16
ADX 17.47
+DI 26.07
-DI 17.90
Chandelier Exit (Long, 3 ATRs ) 2.45
Chandelier Exit (Short, 3 ATRs ) 2.67
Upper Bollinger Band 2.93
Lower Bollinger Band 2.16
Percent B (%b) 0.69
BandWidth 30.13
MACD Line 0.09
MACD Signal Line 0.08
MACD Histogram 0.0099
Fundamentals Value
Market Cap 456.69 Million
Num Shares 170 Million
EPS -1.84
Price-to-Earnings (P/E) Ratio -1.46
Price-to-Sales 3.22
Price-to-Book 2.97
PEG Ratio -1.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.87
Resistance 3 (R3) 2.88 2.82 2.84
Resistance 2 (R2) 2.82 2.78 2.82 2.83
Resistance 1 (R1) 2.76 2.75 2.73 2.75 2.82
Pivot Point 2.70 2.70 2.69 2.70 2.70
Support 1 (S1) 2.64 2.66 2.61 2.63 2.56
Support 2 (S2) 2.58 2.63 2.58 2.55
Support 3 (S3) 2.52 2.58 2.54
Support 4 (S4) 2.51